Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMC 1059760)

Published in J Epidemiol Community Health on June 01, 1993

Authors

C A Brown1, C Bolton-Smith, M Woodward, H Tunstall-Pedoe

Author Affiliations

1: Cardiovascular Epidemiology Unit, Ninewells Hospital and Medical School, Dundee.

Articles cited by this

The Tromsø heart study. Does coffee raise serum cholesterol? N Engl J Med (1983) 4.55

A longitudinal study of coronary heart disease. Circulation (1963) 4.30

A short rating scale as a potential measure of pattern A behavior. J Chronic Dis (1969) 3.85

Concomitants of excess coronary deaths--major risk factor and lifestyle findings from 10,359 men and women in the Scottish Heart Health Study. Scott Med J (1989) 3.38

Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med (1977) 2.98

Coffee, caffeine, and cardiovascular disease in men. N Engl J Med (1990) 2.49

Coronary risk factor and lifestyle variation across Scotland: results from the Scottish Heart Health Study. Scott Med J (1989) 2.23

The Scottish Heart Health Study: objectives and development of methods. Health Bull (Edinb) (1987) 2.11

A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. Hum Nutr Appl Nutr (1983) 2.10

Coffee and cardiovascular disease. Observations from the framingham study. N Engl J Med (1974) 1.92

Social status and coronary heart disease: results from the Scottish Heart Health Study. Prev Med (1992) 1.73

Nutrient intakes of different social-class groups: results from the Scottish Heart Health Study (SHHS). Br J Nutr (1991) 1.67

Coffee and myocardial infarction. N Engl J Med (1973) 1.66

Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ (1990) 1.56

Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol (1987) 1.51

Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet (1990) 1.34

The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med (1989) 1.30

Coffee intake and elevated cholesterol and apolipoprotein B levels in men. JAMA (1985) 1.22

Coffee consumption and mortality. Total mortality, stroke mortality, and coronary heart disease mortality. Arch Intern Med (1978) 1.19

Coffee drinking and death due to coronary heart disease. N Engl J Med (1976) 1.19

Coffee and serum-lipids in coronary heart-disease. Lancet (1966) 1.17

Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. Am J Epidemiol (1990) 1.14

Coffee and cholesterol: is it all in the brewing? The Tromsø Study. BMJ (1988) 1.08

Coffee, dietary habits, and serum cholesterol among men and women 35-49 years of age. Am J Epidemiol (1989) 1.02

The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr (1992) 1.01

Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study. Arch Intern Med (1989) 0.90

Coffee, tea, and plasma cholesterol: the Jerusalem Lipid Research Clinic prevalence study. Br Med J (Clin Res Ed) (1985) 0.89

Coffee, tea and cholesterol. Am J Cardiol (1985) 0.87

Consumption of boiled coffee is correlated with serum cholesterol in Finland. Int J Epidemiol (1990) 0.84

Effects of coffee and tea on lipoproteins and prostanoids. Atherosclerosis (1985) 0.84

Coffee consumption and the incidence of coronary heart disease. N Engl J Med (1987) 0.78

Coffee consumption and serum cholesterol: an epidemiological study in Belgium. Int J Epidemiol (1988) 0.78

Coffee and cardiovascular risk: epidemiological findings in Austria. Int J Epidemiol (1990) 0.77

Coffee consumption and serum cholesterol in the hypertension detection and follow-up program. Am J Epidemiol (1988) 0.77

Articles by these authors

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health (1987) 8.59

Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70

Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 7.51

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94

Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ (2008) 6.13

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67

Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health (1984) 3.95

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet (1997) 3.70

Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ (1997) 3.69

Control of blood pressure in Scotland: the rule of halves. BMJ (1990) 3.55

Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ (1997) 3.40

Concomitants of excess coronary deaths--major risk factor and lifestyle findings from 10,359 men and women in the Scottish Heart Health Study. Scott Med J (1989) 3.38

Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77

Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation (1996) 2.76

Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57

Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health (2000) 2.50

Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol (1990) 2.43

Prevalence of coronary heart disease in Scotland: Scottish Heart Health Study. Br Heart J (1990) 2.42

Differential binding of the insecticidal lectin GNA to human blood cells. Lancet (1999) 2.39

Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32

By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart (2005) 2.32

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28

Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl (1988) 2.26

Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry (2008) 2.24

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. Lancet (2014) 2.18

Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18

Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation (1997) 2.12

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens (2007) 2.01

Statistical approaches for assessing the relative validity of a food-frequency questionnaire: use of correlation coefficients and the kappa statistic. Public Health Nutr (2003) 1.88

Level and trends of coronary heart disease mortality in Scotland compared with other countries. Health Bull (Edinb) (1986) 1.87

Smoking characteristics and inhalation biochemistry in the Scottish population. J Clin Epidemiol (1991) 1.83

Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. J Epidemiol Community Health (1995) 1.83

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ (2013) 1.78

Social status and coronary heart disease: results from the Scottish Heart Health Study. Prev Med (1992) 1.73

Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation (2004) 1.72

Nutrient intakes of different social-class groups: results from the Scottish Heart Health Study (SHHS). Br J Nutr (1991) 1.67

Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr (2000) 1.63

Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63

Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke (2003) 1.60

Geographical variation in coronary heart disease mortality in Scotland. Health Bull (Edinb) (1986) 1.59

Cardiovascular disease in Edinburgh and north Glasgow--a tale of two cities. J Clin Epidemiol (1990) 1.59

A one-quarter reduction in the salt content of bread can be made without detection. Eur J Clin Nutr (2003) 1.57

Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events; the Scottish Heart Health Study Cohort. Eur Heart J (2002) 1.55

Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart (2011) 1.52

Experimental Salmonella enteritidis infection in chicks. Vet Rec (1989) 1.50

Pre-hospital coronary care and coronary fatality in the Belfast and Glasgow MONICA populations. Int J Epidemiol (2005) 1.47

Bias from missing values: sex differences in implication of failed venepuncture for the Scottish Heart Health Study. Int J Epidemiol (1991) 1.45

Geographical clustering of risk factors and lifestyle for coronary heart disease in the Scottish Heart Health Study. Br Heart J (1990) 1.44

The ultrastructure of chronic radiation damage in rat skin. Surg Gynecol Obstet (1981) 1.43

Preventing diabetes complications: are we too glucocentric? Int J Clin Pract (2010) 1.42

Outcome of the Lima periurethral constrictor in children and adolescents: a European perspective. J Urol (2012) 1.38

Potential impact of emergency intervention on sudden deaths from coronary heart disease in Glasgow. Br Heart J (1992) 1.38

Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. BMJ (1995) 1.37

Review by a local medical research ethics committee of the conduct of approved research projects, by examination of patients' case notes, consent forms, and research records and by interview. BMJ (1997) 1.37

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia (2010) 1.36

Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers. Br J Nutr (1991) 1.35

Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr (1997) 1.35

Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health (1999) 1.31

Autres pays, autres moeurs. BMJ (1988) 1.31

Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited. J Hum Hypertens (2003) 1.30

Variation in coronary risk factors by social status: results from the Scottish Heart Health Study. Br J Gen Pract (1992) 1.29

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27

A provisional database for the silicon content of foods in the United Kingdom. Br J Nutr (2005) 1.26

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia (2009) 1.26

Heart disease mortality. BMJ (1989) 1.25

Comment on the ESC/ACC redefinition of myocardial infarction by a consensus dissenter. Eur Heart J (2001) 1.25

Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens (2007) 1.25

European regional variation in cardiovascular mortality. Br Med Bull (1984) 1.24

APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24

Measurement of passive smoking in adults: self-reported questionnaire or serum cotinine? J Cancer Epidemiol Prev (2002) 1.23

Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology (2009) 1.20

The impact of inter-generational social and regional circumstances on dietary intake patterns of British adults: results from the 1946 British Birth Cohort. Public Health Nutr (2004) 1.19

Alcohol consumption and unemployment among men: the Scottish Heart Health Study. Br J Addict (1990) 1.18

The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control (2006) 1.18

Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (1999) 1.17

A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol (2005) 1.17

Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Eur Psychiatry (2011) 1.15

Out-of-hospital cardiac arrest due to coronary heart disease: a comparison of survival before and after the introduction of defribrillators in ambulances. Heart (1996) 1.15

Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr (2003) 1.14

An iterative technique for identifying smoking deceivers with application to the Scottish Heart Health Study. Prev Med (1992) 1.13

Impact of smoking and smoking cessation on lung cancer mortality in the Asia-Pacific region. Am J Epidemiol (2007) 1.13

Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases. Ann Med (1998) 1.11

Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol (1996) 1.11

Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Stroke (2003) 1.11